Performances of a novel chemiluninescence ABEI-based NT-proBNP immunoassay.

Christina Adamantidou, Sylvie Ahn, Michel Rousseau, Damien Gruson

Acta cardiologica 2022 Apr

filter terms:

Natriuretic peptides are widely used in clinical practice as cardiac markers for early diagnosis, prognosis and for the monitoring of treatment efficiency of heart Failure (HF). According to the clinical relevance of natriuretic peptides testing, it is important to assess the performances of novel platform for testing. Our study showed the overall good performances of a new NT-proBNP ABEI-based automated immunoassay.

Citation

Christina Adamantidou, Sylvie Ahn, Michel Rousseau, Damien Gruson. Performances of a novel chemiluninescence ABEI-based NT-proBNP immunoassay. Acta cardiologica. 2022 Apr;77(2):176-179